Testosterone and prostate;Testostérone et prostate

Revue Medicale Suisse

Volumn 7, Issue 320, 2011, Pages 2399-2403

  Vaucher, L ^a   Paduch, D A ^b   Jichlinski, P ^a   Pralong, F ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; CANCER GROWTH; HUMAN; HYPOGONADISM; LOWER URINARY TRACT SYMPTOM; PROSTATE CANCER; PROSTATE DISEASE; REVIEW; ARTICLE; MALE; PHYSIOLOGY; PROSTATE TUMOR;

HUMANS; MALE; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 84856260520     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. **Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-76. (Pubitemid 41428540)
2. Nieschlag E, Swerdloff R, Behre H, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 2006;27:135-7.
3. Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European male aging study. J Clin Endocrinol Metab 2008;93:2737-45. (Pubitemid 352008544)
4. Wang X, Kruithof-de Julio M, Economides K, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009;461:495-500.
5. Demichelis F, Rubin M. TMPRSS2-ETS fusion prostate cancer: Biological and clinical implications. J Clin Pathol 2007;60:1185-6. (Pubitemid 350084536)
6. Tenover JS, Matsumoto AM, Plymate SR, et al. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate. J Clin Endocrinol Metab 1987;65:1118-26. (Pubitemid 18026845)
7. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effet of castration of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res 1941;1:293.
8. Sakr WA, Haas GP, Cassin BF, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85. (Pubitemid 23215874)
9. Morgentaler A, Bruning CO 3rd, DeWolf WC. Occult prostate cancer in men with low serum testosterone levels. JAMA 1996;276:1904-6. (Pubitemid 26419188)
10. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.
11. Stattin P, Lumme S, Tenkanen L, et al. High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study. Int J Cancer 2004;108:418-24. (Pubitemid 37549608)
12. Liverman C, Blaser D. Testosterone and aging: Clinical research directions. Washington DC, 2004.
13. *Marks LS, Mazer NA, Mostaghel E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: A randomized controlled trial. JAMA 2006;296:2351-61. (Pubitemid 44749363)
14. Fowler JE, Whitmore WF. The response of metastatic adenocarcinoma of the prostate to exogenous testosterone. J Urol 1981;126:372-5.
15. **Morgentaler A. Testosterone and prostate cancer: An historical perspective on a modern myth. Eur Urol 2006;50:935-9. (Pubitemid 44486489)
16. Gould DC, Feneley MR, Kirby RS. Prostate-specific antigen testing in hypogonadism: Implications for the safety of testosterone-replacement therapy. BJU Int 2006;98:1-4. (Pubitemid 43885494)
17. Litman HJ, Bhasin S, O'Leary MP, et al. An investigation of the relationship between sex-steroid levels and urological symptoms: Results from the Boston area community health survey. BJU Int 2007;100:321-6. (Pubitemid 47036575)
18. Ozata M, Bulur M, Beyhan Z, et al. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism. Endocr J 1997;44:719-24. (Pubitemid 28011462)